Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis-Reference-Cited by-同舟云学术

Reassessment of Blood Gene Expression Markers for the Prognosis of Relapsing-Remitting Multiple Sclerosis

Published:2011-12-27 Issue:12 Volume:6 Page:e29648
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hecker Michael,Paap Brigitte Katrin,Goertsches Robert Hermann,Kandulski Ole,Fatum Christian,Koczan Dirk,Hartung Hans-Peter,Thiesen Hans-Juergen,Zettl Uwe Klaus

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference88 articles.

1. Multiple sclerosis.;A Compston;Lancet,2008

2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.;S Sawcer;Nature,2011

3. Immunology of multiple sclerosis.;M Sospedra;Annu Rev Immunol,2005

4. Therapy of MS.;R Vosoughi;Clin Neurol Neurosurg,2010

5. Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works.;A Mendes;Arq Neuropsiquiatr,2011

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-Wide Expression Profile in People with Optic Neuritis Associated with Multiple Sclerosis;Biomedicines;2023-08-07

2. An Enhanced Multiple Sclerosis Disease Diagnosis via an Ensemble Approach;Diagnostics;2022-07-21

3. Potential role of inducible GPR3 expression under stimulated T cell conditions;Journal of Pharmacological Sciences;2022-03

4. Detailed neuronal distribution of GPR3 and its co-expression with EF-hand calcium-binding proteins in the mouse central nervous system;Brain Research;2021-01

5. Joint Application of Magnetic Resonance Imaging and Biochemical Biomarkers in Diagnosis of Multiple Sclerosis;Current Medicinal Chemistry;2020-11-24